Actively Recruiting

Phase Not Applicable
Age: 18Years - 89Years
All Genders
Healthy Volunteers
NCT06495138

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

Led by Emory University · Updated on 2025-07-16

138

Participants Needed

1

Research Sites

97 weeks

Total Duration

On this page

Sponsors

E

Emory University

Lead Sponsor

N

National Multiple Sclerosis Society

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study aims to study the effects of a novel treatment for vestibular symptoms in people with multiple sclerosis. The main objective is to determine whether daily personalized gaze stabilization training is more beneficial than intermittent gaze stability training in people with multiple sclerosis.

CONDITIONS

Official Title

Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis

Who Can Participate

Age: 18Years - 89Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Neurologist-confirmed diagnosis of primary progressive or relapsing and remitting MS per The 2017 Revision of the McDonald Criteria and the Magnetic Resonance Imaging in MS, or a healthy volunteer without a diagnosis of multiple sclerosis or any related neurological conditions
  • Fluent in speaking and understanding English
  • Subjects with multiple sclerosis have self-reported vestibular symptoms of dizziness, imbalance, and/or a history of at least two falls in the prior 12 months
Not Eligible

You will not qualify if you...

  • Clinically isolated syndrome or radiologically isolated syndrome
  • Worsening MS symptoms during the prior 60 days
  • Immunotherapy change in the prior 60 days
  • Self-reported cognitive impairment that limits independence with basic and instrumental activities of daily living
  • Systolic blood pressure > 180 mmHg and/or diastolic blood pressure > 90 mmHg at rest
  • Static visual acuity with correction of worse than 1.0 logMAR
  • Manifest ocular misalignment ≥ 5 diopters (e.g., tropia, lazy eye, strabismus)
  • Convergence insufficiency
  • Intra-nuclear ophthalmoplegia
  • Vestibular Migraine
  • Major orthopedic conditions that limit cervical spine range of motion or that alter walking
  • Self-reported current or potential for pregnancy during enrollment
  • Ongoing participation in vestibular rehabilitation for dizziness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Emory Univeristy

Atlanta, Georgia, United States, 30329

Actively Recruiting

Loading map...

Research Team

C

Colin Grove, PT, DPT, MS, PhD

CONTACT

C

Colin Grove

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here